|
1
|
Shi HY, Zhu SC, Shen WB and Liu ML:
Pathological characteristics of esophageal cancer. Oncol Lett.
8:533–538. 2014.PubMed/NCBI
|
|
2
|
Tomochika S, Iizuka N, Watanabe Y, Tsutsui
M, Takeda S, Yoshino S, Ichihara K and Oka M: Increased serum
cell-free DNA levels in relation to inflammation are predictive of
distant metastasis of esophageal squamous cell carcinoma. Exp Ther
Med. 1:89–92. 2010.PubMed/NCBI
|
|
3
|
Tan Y, Chen B, Xu W, Zhao W and Wu J:
Clinicopathological significance of CD133 in lung cancer: A
meta-analysis. Mol Clin Oncol. 2:111–115. 2014.PubMed/NCBI
|
|
4
|
He A, Qi W, Huang Y, Feng T, Chen J, Sun
Y, Shen Z and Yao Y: CD133 expression predicts lung metastasis and
poor prognosis in osteosarcoma patients: A clinical and
experimental study. Exp Ther Med. 4:435–441. 2012.PubMed/NCBI
|
|
5
|
Bodzin AS, Wei Z, Hurtt R, Gu T and Doria
C: Gefitinib resistance in HCC Mahlavu cells: Upregulation of CD133
expression, activation of IGF-1R signaling pathway, and enhancement
of IGF-1R nuclear translocation. J Cell Physiol. 227:2947–2952.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ferrandina G, Bonanno G, Pierelli L,
Perillo A, Procoli A, Mariotti A, Corallo M, Martinelli E, Rutella
S, Paglia A, et al: Expression of CD133-1 and CD133-2 in ovarian
cancer. Int J Gynecol Cancer. 18:506–514. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kojima M, Ishii G, Atsumi N, Fujii S,
Saito N and Ochiai A: Immunohistochemical detection of CD133
expression in colorectal cancer: A clinicopathological study.
Cancer Sci. 99:1578–1583. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hang D, Dong HC, Ning T, Dong B, Hou DL
and Xu WG: Prognostic value of the stem cell markers CD133 and
ABCG2 expression in esophageal squamous cell carcinoma. Dis
Esophagus. 25:638–644. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zimmerer RM, Korn P, Demougin P, Kampmann
A, Kokemüller H, Eckardt AM, Gellrich NC and Tavassol F: Functional
features of cancer stem cells in melanoma cell lines. Cancer Cell
Int. 13:782013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang AP: The expression of marker cancer
stem cells CD133 and Musashi-1 in human esophageal carcinoma and
its clinical significances. Southeast Univ. 15:6982010.(In
Chinese).
|
|
11
|
Cao YK: Relationship between CD133
expression and chemoradio therapy response in esophageal squamous
cell carcinoma. Zhongshan Univ. 16:752009.(In Chinese).
|
|
12
|
Fei ZH, Chen SX and Chen L: Expression and
significance of Bmi-1 and CD133 in esophageal squamous cell
carcinoma. Mod Pract Med. 23:3372011.(In Chinese).
|
|
13
|
Feng KX, Li SP, Liu XL, Zhou J, Yuan S,
Xie MH, Jing DS and Sun YZ: Expression of NF-κB, CD133 in
esophageal cancer and correlation with metastasis. Mod Oncol.
23:02062014.(In Chinese).
|
|
14
|
Wang YW, Zhang J and Feng G: Expression of
CD133 in esophageal squamous cell carcinoma and its clinical
significance. Shaanxi Med J. 43:14642014.(In Chinese).
|
|
15
|
Okamoto H, Fujishima F, Nakamura Y, et al:
Significance of CD133 expression in esophageal squamous cell
carcinoma. World J Surg Oncol. 11:512013.(In Chinese). View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng J, Guo JJ, Ao X, Zhou TJ, Wang M, Li
YQ and Zhang HZ: Expression of CDl33 in the tissue of locally
advanced esophagus squamous cell cancer patients and its
significance. Chin J Exp Surg. 29:5412012.(In Chinese).
|
|
17
|
Ning Z, Zhu H, Li F, Liu Q, Liu G, Tan T,
Zhang B, Chen S, Li G, Huang D, et al: Tumor suppression by miR-31
in esophageal carcinoma is p21-dependent. Genes Cancer. 5:436–444.
2014.PubMed/NCBI
|
|
18
|
Rios-Galvez S, Meixueiro-Daza A and
Remes-Troche JM: Achalasia: a risk factor that must not be
forgotten for esophageal squamous cell carcinoma. BMJ Case Rep.
2015(pii): bcr20142044182015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shimizu Y, Takahashi M, Mizushima T, Ono
S, Mabe K, Ohnishi S, Kato M, Asaka M and Sakamoto N:
Chromoendoscopy with iodine staining, as well as narrow-band
imaging, is still useful and reliable for screening of early
esophageal squamous cell carcinoma. Am J Gastroenterol.
110:193–194. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nguyen LV, Vanner R, Dirks P and Eaves CJ:
Cancer stem cells: An evolving concept. Nat Rev Cancer. 12:133–143.
2012.PubMed/NCBI
|
|
21
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Klein WM, Wu BP, Zhao S, Wu H,
Klein-Szanto AJ and Tahan SR: Increased expression of stem cell
markers in malignant melanoma. Mod Pathol. 20:102–107. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lobo NA, Shimono Y, Qian D and Clarke MF:
The biology of cancer stem cells. Annu Rev Cell Dev Biol.
23:675–699. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vermeulen L, Sprick MR, Kemper K, Stassi G
and Medema JP: Cancer stem cells - old concepts, new insights. Cell
Death Differ. 15:947–958. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu S, Liu C, Min X, Ji Y, Wang N, Liu D,
Cai J and Li K: Prognostic value of cancer stem cell marker
aldehyde dehydrogenase in ovarian cancer: A meta-analysis. PLoS
One. 8:e810502013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yao Q, Sun JG, Ma H, Zhang AM, Lin S, Zhu
CH, Zhang T and Chen ZT: Monitoring microRNAs using a molecular
beacon in CD133+/CD338+ human lung
adenocarcinoma-initiating A549 cells. Asian Pac J Cancer Prev.
15:161–166. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Simon R and Altman DG: Statistical aspects
of prognostic factor studies in oncology. Br J Cancer. 69:979–985.
1994. View Article : Google Scholar : PubMed/NCBI
|
